全文获取类型
收费全文 | 41891篇 |
免费 | 2475篇 |
国内免费 | 1658篇 |
专业分类
耳鼻咽喉 | 307篇 |
儿科学 | 893篇 |
妇产科学 | 548篇 |
基础医学 | 6901篇 |
口腔科学 | 930篇 |
临床医学 | 4257篇 |
内科学 | 5770篇 |
皮肤病学 | 1233篇 |
神经病学 | 1755篇 |
特种医学 | 903篇 |
外国民族医学 | 7篇 |
外科学 | 2012篇 |
综合类 | 6535篇 |
现状与发展 | 4篇 |
预防医学 | 2924篇 |
眼科学 | 424篇 |
药学 | 7195篇 |
14篇 | |
中国医学 | 1276篇 |
肿瘤学 | 2136篇 |
出版年
2024年 | 79篇 |
2023年 | 451篇 |
2022年 | 1012篇 |
2021年 | 1335篇 |
2020年 | 1124篇 |
2019年 | 987篇 |
2018年 | 989篇 |
2017年 | 1071篇 |
2016年 | 1064篇 |
2015年 | 1177篇 |
2014年 | 2239篇 |
2013年 | 2304篇 |
2012年 | 2315篇 |
2011年 | 2754篇 |
2010年 | 2233篇 |
2009年 | 2104篇 |
2008年 | 2233篇 |
2007年 | 2331篇 |
2006年 | 1949篇 |
2005年 | 1990篇 |
2004年 | 1632篇 |
2003年 | 1565篇 |
2002年 | 1313篇 |
2001年 | 1136篇 |
2000年 | 1073篇 |
1999年 | 1033篇 |
1998年 | 929篇 |
1997年 | 810篇 |
1996年 | 652篇 |
1995年 | 721篇 |
1994年 | 618篇 |
1993年 | 450篇 |
1992年 | 405篇 |
1991年 | 289篇 |
1990年 | 211篇 |
1989年 | 162篇 |
1988年 | 141篇 |
1987年 | 122篇 |
1986年 | 95篇 |
1985年 | 152篇 |
1984年 | 143篇 |
1983年 | 113篇 |
1982年 | 114篇 |
1981年 | 107篇 |
1980年 | 74篇 |
1979年 | 51篇 |
1978年 | 39篇 |
1977年 | 42篇 |
1976年 | 38篇 |
1973年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
[背景]观察抗结核药物的不良反应.[病例报告]对293例应用抗结核药物后出现不良反应的患者资料进行分析,抗结核药物常见不良反应的有肝脏损害、胃肠道反应、听力障碍及关节痛等.[讨论]应依据患者的具体情况,选择不同的抗结核药物进行联合应用. 相似文献
42.
Hideaki Iwaki Kazuyoshi Johnin Susumu Kageyama Chul Jang Kim Takahiro Isono Tatsuhiro Yoshiki 《International journal of urology》2007,14(10):918-923
OBJECTIVES: Vesicoureteral reflux (VUR) is the most common congenital urinary tract anomaly. This disease can pose a major threat to the kidneys as twenty percent of patients with endstage renal disease are reported to have VUR. Although genetic studies for uroplakin III (UPIII) have been reported recently, no study has focused on UPIII gene expression in VUR patients. We describe here the up-regulation of UPIII mRNA in exfoliated urinary cells from primary VUR patients. METHODS: A real-time RT-PCR for UPIII mRNA was performed on exfoliated urothelial cells from 18 primary VUR and 38 control samples. UPIII mRNA copies were calculated for each sample. The statistical differences were assessed by the Mann-Whitney U test. Receiver operator characteristic curves were constructed for analysis of the diagnostic values. RESULTS: UPIII mRNA was found to be up-regulated to a greater extent in VUR than in control exfoliated urinary cells (mean +/- SE: 497.0 +/- 178.5 copies vs. 69.0 +/- 10.0 copies, respectively, P < 0.001). In evaluating the measurement of urinary UPIII mRNA as a screening test for VUR, the sensitivity was 77.8% and the specificity was 76.3% by the best diagnostic cutoff point. CONCLUSIONS: This is the first report demonstrating up-regulation of UPIII in mRNA levels in VUR patients. We submit that the quantitative measurement of urinary UPIII mRNA has a potential of developing into the first non-invasive screening test for VUR. 相似文献
43.
44.
The interactive role of mucosal T lymphocytes in intestinal growth, development and enteropathy 总被引:2,自引:0,他引:2
Abstract Over the past 15–20 years, research has progressively focused on the mucosal T cell as the central factor in the initiation of physiological or pathological changes, first in the growth and maturation of the early (postnatal) intestine, and second in adult-type enteropathies resulting from sensitivity to either food or pathogen-derived antigens. T cell-mediated events may be measured, for example, in terms of specific immunopathologic patterns of change and injury, such as type 1 (lymphocyte infiltration), type 2 (crypt hyperplasia) and type 3 (flat-destructive), which can be recognized and quantitated microscopically; by determination of lymphocyte reactivity through secretion of interleukin-2 receptors (IL-2R) into plasma or expression by mucosal lymphocytes; by quantitation of lymphocyte subsets emigrating into inflamed tissues by immunoperoxidase-labelled monoclonal antibodies; or by the determination of T cell receptor polymorphisms. Alterations in intestinal growth, structure and function at weaning are likely to be T cell-mediated as they are analogous to the same type 1/2 lesions that reflect modulation of adult mucosal architecture in food and parasite-induced hypersensitivity reactions. Enteropathies associated with HIV infection and T cell deficiency display a milder degree of villous flattening and impaired crypt hyperplasia than that typical of gluten-sensitivity, suggesting a reversion to lesser degrees of mucosal pathology (type 1/2). Clearly more information will accrue; meanwhile the remarks in this brief survey should provide a firm basis whereby clinician and scientist can meet, and together recognize and further dissect the modulatory effect of T lymphocytes on mucosal structure and function. 相似文献
45.
ltiswellknownthattheskinofextensivelyburnedcasesthemselvesisinsufficienttoprovidecoverageforwounds.Thoughallogeneicskincancoverthewoundstemporari1y,itwillberejectedwithin2-3weeks.Thiscanthreatenthepatient'slifeifthereisnoenoughautogenousskintoreplacetherejectedoneontime.GreenetalL1]reportedthattheburnwoundsofpatientswithextensiveburnscouldbetreatedbytransplantingepidermalautograftsafterautologousepidermalcellsmulti-plyforthousandsoftimesinvltrowithinashortperiodoftime-Butittakesatleast2-3weeks… 相似文献
46.
以环己酮为起始原料,经与苯肼缩合、氧化、Mannich 反应制得1,2,3,9-四氢-3-二甲胺基甲基-4H-咔唑-4-酮盐酸盐(5),后者再与2-甲基咪唑缩合、甲基化合成翁丹西隆,总收率为10.4%。 相似文献
47.
HBV-M定量检测与HBV-DNA含量水平关系的初步探讨 总被引:2,自引:0,他引:2
目的 研究乙型肝炎病毒标志物定量检测结果与其HBV-DNA含量的临床关系。方法 采用时间分辨免疫定量和荧光定量-PCR技术,对HBV-DNA和HBV-DNA含量进行检测。结果 在HBsAg/HBeAg/HBcAb,HBsAg/HBcAb/HBcAb,HBeAg/IC及单纯HBcAb阳性的四个组别中,HBV-DNA阳性率分别是97.17%、30.56%、100%和25%;在HBsAg,HBeAg,HBeAb,HBcAb定量检测高,低值两组HBV-DNA含量对比中,HBV-DNA阳性率分别为76.92%、58.14%;100%、97.26%;20.00%、11.42%;64.62%、27.63%。结论 HBV-DNV比HBV-M更能及时准确反映乙型肝炎病毒感染者的病程情况。 相似文献
48.
49.
G. Miremont F. Haramburu B. Bégaud J. C. Péré J. Dangoumau 《European journal of clinical pharmacology》1994,46(4):285-289
Since spontaneous reporting of adverse drug reactions depends on the physician's opinion of the relationship between the drug and the adverse event, we compared physicians' opinions with the scores obtained by the causality assessment method used in France. During a 2 month period, all physicians who reported adverse drug reactions (ADRs) to our pharmacovigilance centre expressed their opinions on the causal link by means of visual analogue scales. ADR reports were then assessed with the French causality assessment method by a clinical pharmacologist who was blind to physicians' opinions.The assessment by both physicians and the standardized method was performed for 75 ADR cases involving 120 drugs. Physicians used a wide range of assessments, with a preponderance of extreme scores, resulting in a U-shaped distribution, while the standardized method gave generally low scores. Scores given by physicians were very high (causality considered very likely or likely) in 60% of cases and very low (causality considered unlikely or dubious/possible) in 32% of cases. Scores obtained using the causality assessment method were low (causality dubious/possible) in 89% of cases and causality considered likely in only 11 cases, essentially in cases with positive rechallenge. Complete agreement occurred in only 6% of cases. Adding complete agreement and minor discrepancies raised the percentage to 49%. 相似文献
50.
Non-ionic contrast media (CM) are proven to be significantly safer than the high osmolar ionic contrast media (HOCM). Nevertheless deaths are reported after administration of non-ionic agents. The aim of the study was to investigate the rate of adverse reactions to non-ionic CM with special regard to high-risk patients and the effects of premedication with H1-and H2-receptor antagonists.In a prospective study conducted over about 2 years 12 995 examinations with intravenous or intra-arterial non-ionic CM were evaluated. Premedication with H1-and H2-antagonists was used in 1276 high-risk patients with known adverse reaction to CM, history of allergy or severe cardiac or pulmonary disease. 229 patients received no premedication inspite of known risk factors. In total, there were 143 (1.10%) adverse reactions (mild in 0.58%, moderate in 0.41% and severe in 0.05%). In high-risk patients there were adverse reactions in 4.37% without and in 1.57% with premedication. There were no severe adverse reactions in the high-risk patients after premedication. The age of the patient, CM dosage and CM concentration were not shown to be risk factors in the present study. In conclusion, the additional premedication with H1- and H2-antagonists could be an effective agent to reduce the risk of mild and moderate adverse reactions and to avoid severe adverse reactions in high-risk patients.
Correspondence to: U. Fink 相似文献